Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Released disappointing clinical trial data on its new pain relief medication, where the effect of the medication was comparable to the placebo arm.
— Dr. Hendrik Leber
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Vertex Pharmaceuticals Incorporated
More institutional theses from ACATIS Investment
Equinor ASA ($EQNR) was sold to take profits after its share price nearly doubled following tensions around the Strait of Hormuz.
Panasonic Holdings Corporation ($PCRFY) was divested after substantial gains in AI-driven data center components pushed its valuation into overvalued territory.
Coinbase Global ($COIN) operates a leading digital asset exchange and institutional infrastructure ecosystem providing trading, custody, and staking services for cryptocurrencies. The investment manager...